The American Journal of Surgery
Volume 194, Issue 2 , Pages 148-152 , August 2007

Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor

  • Kai-Hsi Hsu, M.D.

      Affiliations

    • Department of Surgery, Tainan Hospital, Department of Health, Executive Yuan, 125, Jhong-Shan Rd, Tainan 700, Taiwan, ROC
    • Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, 138, Sheng-Li Rd, Tainan 70428, Taiwan, ROC
    • ,
  • Ta-Ming Yang, M.D.

      Affiliations

    • Department of Surgery, Tainan Municipal Hospital, 670, Chung-Te Rd, Tainan 701, Taiwan, ROC
    • ,
  • Yan-Shen Shan, M.D., Ph.D.

      Affiliations

    • Department of Surgery, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138, Sheng-Li Rd., Tainan 70428, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +011-886-6-2353535-5182; fax: +011-886-6-276-6676.
    • ,
  • Pin-Wen Lin, M.D.

      Affiliations

    • Department of Surgery, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138, Sheng-Li Rd., Tainan 70428, Taiwan, ROC

Received 5 May 2006 ,Revised 3 October 2006

References 

  1. Mazur MT, Clark HB. Gastric stromal tumors (Reappraisal of histogenesis). Am J Surg Pathol. 1983;7:507–559
  2. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT) (Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal). Am J Pathol. 1998;152:1259–1269
  3. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-KIT in human gastrointestinal stromal tumors. Science. 1998;279:577–580
  4. Demetri GD, Mehren MV, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–480
  5. Savage DG, Antman KH. Imatinib mesylate—a new oral targeted therapy. N Engl J Med. 2002;346:683–693
  6. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118–8121
  7. Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease. Eur J Cancer. 2002;38(suppl 5):S37–S38
  8. Shinomura Y, Kinoshita K, Tsutsui S, et al. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors. J Gastroenterol. 2005;40:775–780
  9. DeMatteo RP, Heinrich MC, El-Rifai W, et al. Clinical management of gastrointestinal stromal tumors: before and after STI571. Hum Pathol. 2002;33:466–477
  10. Nilsson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. Cancer. 2005;103:821–829
  11. Iesalnieks I, Rummele P, Dietmaier W, et al. Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era. Am J Clin Pathol. 2005;124:740–748
  12. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–465
  13. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–58
  14. Yan H, Marchettini P, Acherman YI, et al. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol. 2003;26:221–228
  15. Rossi CR, Mocellin S, Mencarelli R, et al. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer. 2003;107:171–176
  16. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005;100:162–168
  17. Wu PC, Langerman A, Ryan CW, et al. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery. 2003;134:656–665
  18. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002;38(suppl 5):S39–S51
  19. Kwon SJ Korean Gastric Cancer Study Group. Surgery and prognostic factors for gastric stromal tumor. World J Surg. 2001;25:290–295
  20. Heinrich MC, Corless CL. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol. 2005;90:195–207
  21. Takahashi R, Tanaka S, Kitadai Y, et al. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology. 2003;64:266–274
  22. Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer. 2003;6:39–48
  23. Schneider-Stock R, Boltze C, Lasota J, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol. 2003;21:1688–1697
  24. Dei Tos AP. The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution. Virchows Arch. 2003;442:421–428
  25. Rudolph P, Gloeckner K, Parwaresch R, et al. Immunophenotype, proliferation, DNA-ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. Hum Pathol. 1998;29:791–800
  26. Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol. 2002;20:3898–3905
  27. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol. 1999;30:1213–1220
  28. Verweij J, Casali P, Zalcberg J, et al. Improved progression free survival in gastro-intestinal stromal tumors with high dose Imatinib (Results of a randomized phase III study of the EORTC, ISG and AGITG). Lancet. 2004;364:1127–1134

PII: S0002-9610(07)00334-0

doi: 10.1016/j.amjsurg.2006.10.033

The American Journal of Surgery
Volume 194, Issue 2 , Pages 148-152 , August 2007

Article Tools

* Image Usage & Resolution